Clinical Trial Update: Evaluation of Immunogenicity Levels in Women With HPV Vaccine in Mexico [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating immunogenicity levels of an HPV vaccine in healthy women in Mexico.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Human Papillomavirus Infection

Snippet

Sponsor: Instituto Nacional de Salud Publica, Mexico | Conditions: Healthy | Phase 4 | Status: COMPLETED